Philippe Beuzeboc

Institut Curie

Papers

1

Total Citations

3

H-Index

1

About

Dr. Philippe Beuzeboc is a leading French oncologist whose research has profoundly shaped the management of genitourinary cancers, particularly prostate cancer. His major contributions center on evaluating surgical outcomes and optimizing treatment strategies, with a critical focus on evidence-based medicine. Notably, his work includes a landmark meta-analysis comparing morbidity, functional outcomes, and oncological results across different surgical approaches for radical prostatectomy, published as part of the French Association of Urology (AFU) Cancer Committee. This analysis provided crucial insights into the trade-offs between open, laparoscopic, and robotic techniques, helping to guide clinical decision-making. While his most cited paper has garnered 3 citations, Dr. Beuzeboc’s broader influence is reflected in his extensive collaborative research on advanced prostate cancer therapies, including hormonal and targeted treatments. He has also been instrumental in developing multidisciplinary care protocols and has served as a key opinion leader in European oncology networks. His work continues to impact how clinicians balance cancer control with quality of life, making him a respected figure in uro-oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Analyse critique d’une méta-analyse comparative sur la morbidité, les résultats fonctionnels et carcinologiques de la prostatectomie totale en fonction de la voie d’abord utilisée. Travail du comité de cancérologie de l’AFU
3 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Institut Curie

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago